Author/Authors :
Bonomini Mario نويسنده Unit of Nephrology and Dialysis, Department of Medicine,
“SS. Annunziata” University Hospital, Chieti, Italy , Pandolfi Assunta نويسنده Aging Research Center and Translational Medicine CeSI-MeT,
“G. d’Annunzio” University, Chieti-Pescara, Italy , Sirolli Vittorio نويسنده Unit of Nephrology and Dialysis, Department of Medicine,
“SS. Annunziata” University Hospital, Chieti, Italy , Arduini Arduino نويسنده Department of Research and Development, Core Quest Sagl,
Tecnopolo, Manno, Switzerland , Liberato Lorenzo Di نويسنده Unit of Nephrology and Dialysis, Department of Medicine,
“SS. Annunziata” University Hospital, Chieti, Italy , Pietro Natalia Di نويسنده Aging Research Center and Translational Medicine CeSI-MeT,
“G. d’Annunzio” University, Chieti-Pescara, Italy
Abstract :
Patients suffering from chronic renal failure have a higher burden
of cardiovascular events, which increases in a dose-dependent fashion as
renal function worsens. Increased cardiovascular risk in these patients
is thought to be mediated by the simultaneous presence of both
traditional and non-traditional cardiovascular risk factors, the latter
being associated with renal impairment. Red blood cells are usually
considered as carries of nutrients for tissues and respiratory gases,
less so as compartments essential to vascular integrity. However,
erythrocyte number, size, and integrity seem to severely affect
cardiovascular morbidity and mortality as established in recent clinical
studies with large patient cohorts. In particular, the role of red blood
cells in chronic renal failure tends only to be considered exclusively
in relation to a change in their number. However, these cells in the
uremic milieu are prone to many alterations, which may adversely affect
the cardiovascular system. In this review, we highlight the main
qualitative erythrocyte alterations that may have a pathophysiologic
role in the elevated cardiovascular risk of chronic renal failure.